Projects funded by the NCN
Aptamer-based biosensor for simultaneous detection of thrombin and von Willebrand factor in plasma.
2016/21/N/NZ5/01439
Keywords:
biosensor aptamer thrombin vWF
Descriptors:
- NZ5_5: Diagnostics in human diseases
- NZ5_6: Diagnostics in animal diseases
- ST5_9: Biomaterials, biocompatible materials
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 11 - announced on 2016-03-15
Amount awarded: 149 940 PLN
Project start date (Y-m-d): 2017-02-03
Project end date (Y-m-d): 2020-02-02
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Laptop (3 500 PLN)
- Pipeta wielokanałowa (4 000 PLN)
Information in the final report
- Publication in academic press/journals (1)
- Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow ConditionsAuthors:Katarzyna Derszniak, Kamil Przyborowski, Karolina Matyjaszczyk, Martijn Moorlag, Bas de Laat, Maria Nowakowska and Stefan ChlopickiAcademic press:Frontiers in Pharmacology (rok: 2019, tom: 10, strony: 68), Wydawca: Frontiers Media S.A.Status:PublishedDOI:10.3389/fphar.2019.00068 - link to the publication